Results 161 to 170 of about 243,754 (245)

Integrated Transcriptomic and Machine Learning Analyses Identify KCNN3 and TLR10 as Candidate Cell-Type-Associated Molecules in Idiopathic Membranous Nephropathy. [PDF]

Int J Gen Med
Zhao B, Liu F, Xie B, Pang S, Tan Q, Li S, Wei M, Huang Y, Wei Y, Luo W, Wang P, Su J, Li B, Yang R, Li W.   +14 more
europepmc   +1 more source

A comparative study on the efficacy of rituximab combined with tacrolimus and methylprednisolone in the treatment of patients with moderate-high risk idiopathic membranous nephropathy. [PDF]

Am J Transl Res
Li W, Wang Z, Xiao Z.
europepmc   +1 more source

Efficacy of immunosuppressive therapy in low-risk and intermediate- risk idiopathic membranous nephropathy patients : a 2-year follow-up study. [PDF]

BMC Nephrol
Jin Y, Zhang Y, Chen W, Lan L, Chen C, Jiang J, Jiang J.   +6 more
europepmc   +1 more source

Transcriptomic analysis of differential expression and correlation of coding and non-coding RNAs in urine from patients with idiopathic membranous nephropathy. [PDF]

Biol Direct
Li J, Zhou Z, Wu R, Chen Q.
europepmc   +1 more source

INPP5D/SHIP1-mediated immunometabolic remodeling of renal monocytes in idiopathic membranous nephropathy. [PDF]

Front Immunol
Dai H, Liu B, Rui H, Yang L, Jiang H, Zhao Q, Liu W.   +6 more
europepmc   +1 more source

FSTIV score is essential for clinical management and predicts outcome of idiopathic membranous nephropathy. [PDF]

BMC Nephrol
Liu Y, Wang M, Yang L, Ma J, Zhang G, Bao L, Ma L, Xia W, Zheng Y.   +8 more
europepmc   +1 more source

Evolution of idiopathic membranous nephropathy to class v lupus nephritis: a case report and literature review. [PDF]

Front Med (Lausanne)
Shen B, Peng C, Xiao W.
europepmc   +1 more source

Evaluating rituximab against cyclophosphamide or cyclosporine in idiopathic membranous nephropathy: a meta-analysis. [PDF]

Eur J Med Res
Zhang Y, Chen H, Zhang H, Huang Y.
europepmc   +1 more source

Clinicopathological characteristics and outcomes in patients with diabetic nephropathy coexisting idiopathic membranous nephropathy: a retrospective observational study. [PDF]

Ren Fail
Li Z, Han Y, Yuan S, Xiao L, Zhu X, Sun L.   +5 more
europepmc   +1 more source

Baicalin ameliorates podocyte injury and renal function impairment in idiopathic membranous nephropathy by inhibiting the AGE/RAGE signaling. [PDF]

Ren Fail
Lou C, Zhou Y, Feng B, Fan X, Xu X, Hu P, Wang X.   +6 more
europepmc   +1 more source